Trulieve to list on NYSE June 10 📈

NYSE
Trulieve to list on NYSE June 10 📈

What happened: Trulieve will become the first U.S. cannabis company to list on the New York Stock Exchange. Shares will begin trading on June 10 under the ticker TRLV.

CEO Kim Rivers carved out Trulieve's recreational operations into a separate entity, bringing in outside investor Whitley Holding for $14.8 million to take a 10% voting stake — enough to make the split real under accounting rules. 

Shares popped over 35% on Friday. $TCNNF ( ▲ 4.04% )

The NYSE didn’t immediately respond to a request for comment.

What they’re saying: “Common sense action by President Trump to reclassify medical marijuana to Schedule III paved the way for this historic milestone,” Rivers said in a statement.

Go deeper: The Trump Administration’s rescheduling order applies to medical cannabis, and given the company’s large medical footprint in Florida, it makes sense.

All U.S. cannabis firms are now scrambling to take advantage of the window that rescheduling creates, in an effort to move their listings from over-the-counter to major exchanges like NYSE. 

Curaleaf and Verano announced reverse stock splits to meet NYSE price requirements. TerrAscend on Friday called a shareholder meeting to do the same. And Robinhood added Trulieve, Green Thumb Industries, and Curaleaf to its platform last week, opening the door for potentially millions of retail investors.

“Uplisting to a major U.S. exchange is no longer a question of if, it’s a question of when,” TerrAscend’s Jason Wild said. 

What’s next: The DEA holds hearings June 29 on whether rescheduling extends to recreational cannabis. That outcome will determine how far this wave goes.

Expect every MSO to explore whether the path Trulieve laid will be the one they follow. 

-JB

“The overlap between tourism and cannabis culture presents a powerful opportunity for licensed operators,” Newly confirmed Office of Cannabis Management Executive Director John Kagia told the New York Post about the World Cup coming to the city.

“We have great cannabis products in New York.”

Governor and lawmakers inch toward cannabis sales compromise 🤝

Gov. Abigail Spanberger met directly with the sponsors of the recreational sales bill she vetoed last month, with sources saying a deal could be tucked into budget legislation due by July 1. A delayed market launch is likely, but the harsh criminal penalties she previously proposed probably are not.

White House signals openness to hemp-derived CBD reform 🌿

The Trump administration's OMB wants Congress to update the statutory definition of hemp-derived cannabinoid products to allow access to "appropriate full-spectrum CBD products" while restricting those that "pose serious health risks." The ask appeared in the White House's Statement of Administration Policy on the FY2027 agriculture spending bill.

GOP lawmakers pressure Bessent to block 280E relief 🏛️

Sen. James Lankford (R-OK) and House Budget Chairman Jodey Arrington (R-TX), two longtime cannabis opponents in Congress, wrote to Treasury Secretary Scott Bessent raising concerns about potential 280E tax relief following rescheduling. The pair are particularly troubled by the prospect of retroactive relief, questioning how the Treasury would screen out illicit operators and how many prior tax years are under consideration. Response deadline: June 29.

Canadian cannabis exporters push for more government support abroad 🍁

Representatives from Canada's cannabis industry met with the Canadian Trade Commissioner Service at Canada's High Commission in London last month, pressing for stronger federal backing as global competition intensifies. Canada exported over 76,700 kg of dried cannabis in March 2026 alone, with Germany and Australia as top destinations

Friday’s This Week in Cannabis Live was a good one. Jay, Jeremy, and Marc broke down Trulieve’s move to list on the NYSE, and much, much more.

In case you missed it »

Reframe Beverage, a THC spirits company, assembled an advisory board of beverage alcohol veterans with backgrounds at Diageo, Southern Glazer's, and Moët Hennessy.